Washington, DC (May 23, 2019) -- A new study published in CJASN found substantial volume overload, or too much fluid in the body, in patients with kidney failure who initiated peritoneal dialysis. Volume overload tended to improve over time after starting dialysis, but was at all times was higher in males vs. females and in patients with diabetes vs. those without. The study also revealed variations in practice of care across different geographic regions. This variation was associated with differences in degree of volume overload.
Individuals with kidney failure who are undergoing hemodialysis or peritoneal dialysis often experience fluid overload. To examine the implications of this condition, Wim Van Biesen, MD, PhD (University Hospital Ghent, in Belgium) and his colleagues designed a study to assess patients' health and fluid volume over time after initiating peritoneal dialysis. It's thought that actively managing volume overload may reduce the risk of technique failure (transfer from peritoneal dialysis to hemodialysis) and prolong patient survival.
In the study of 1,054 patients from 28 countries who were examined every 3 months, volume overload before the start of dialysis amounted to an average of 1.9 L and decreased to 1.2 L during the first year. After 3 years of follow-up, the average relative volume overload in patients was lower than at the start in participants from all regions except those of Latin American, where it increased. The investigators concluded that volume overload is already present before the start of dialysis, and it tends to improve over the first 6 months and stabilize afterwards.
At all time points, males and participants with diabetes were at a higher risk of experiencing volume overload. Also, volume overload was associated with a higher risk of premature death. The study revealed different treatment practices to address volume overload across dialysis centres and regions.
"We intended to associate practices of peritoneal dialysis--use of hypertonic exchanges, use of automated peritoneal dialysis vs. continuous ambulatory peritoneal dialysis, use of icodextrin, and use of diuretics--with technique failure. Our main finding is that the association between technique failure and fluid overload is dependent upon centre size and thus presumably experience within the treating centre," said Dr. Van Biesen.
In an accompanying Patient Voice editorial, Shari Gilford shared her experience of peritoneal dialysis, both ambulatory and automated, for 7 years. She also questioned why patients in Latin America had a different outcome than those from other regions.
"If there are factors other than dialysate type, dialysate concentrate, or diet which make it more difficult for patients to control their volume overload, patients need to be made aware of this," she wrote. "Based on my own experience [in hot vs. cold seasons], I wonder if the year-round hotter climate of Latin America, as opposed to most other regions in the study which have cold seasons, could have been a factor for fluid overload leading to increased mortality. Continued study of this variable might improve outcomes for peritoneal dialysis patients who live in warmer climes."
Study co-authors include Christian Verger, MD, James Heaf, MD, PhD, François Vrtovsnik, MD, PhD, Zita Leme Britto, MD, Jun-Young Do, MD, PhD, Mario Prieto Velasco, MD, PHD, Juan Pérez Martínez, MD, PhD, Carlo Crepaldi, MD, PhD, Tatiana De los Ríos, Adelheid Gauly, PhD, Katharina Ihle, and Claudio Ronco, MD, PhD, for the IPOD-PD Study Group.
Disclosures: The study was sponsored by Fresenius Medical Care, the producer of the BCM® device that was used to assess fluid status and nutritional status. Tatiana De los Ríos, Adelheid Gauly, and Katharina Ihle are employees of Fresenius Medical Care The other authors did not report any financial conflicts of interest.
The article, entitled "Evolution Over Time of Hydration Status and PD Related Practice Patterns in an Incident Peritoneal Dialysis Patient Cohort," will appear online at http://cjasn.
The editorial, entitled "Managing Fluid Control in the Peritoneal Dialysis Population," will appear online at http://cjasn.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 20,000 members representing 131 countries. For more information, please visit http://www.